MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue75,589138,882109,61989,650
Cost of Revenue49,99672,46741,17352,585
Gross Profit25,59366,41568,44637,065
Operating Expenses
Research Development74,00876,75978,70773,448
Selling General and Administrative85,10582,20764,46648,051
Non Recurring----
Others30,00030,00030,00030,000
Total Operating Expenses239,109231,433184,346174,084
Operating Income or Loss-163,520-92,551-74,727-84,434
Income from Continuing Operations
Total Other Income/Expenses Net-12,5414,45553,7241,121
Earnings Before Interest and Taxes-163,520-92,551-74,727-84,434
Interest Expense----
Income Before Tax-176,061-88,096-21,003-83,313
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-176,061-88,096-21,003-83,313
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-176,061-88,096-21,003-83,313
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-176,061-88,096-21,003-83,313